Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sentinel lymph node mapping in breast cancer.

H S Cody1

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Oncology (Williston Park, N.Y.)
|February 23, 1999
PubMed
Summary

Sentinel lymph node (SLN) biopsy is a safe and effective procedure for early-stage breast cancer patients. This minimally invasive technique accurately predicts lymph node status, reducing the need for extensive axillary dissection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of sentinel node biopsy in patients having neoadjuvant chemotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2010
Same author

Sentinel lymph node mapping in breast cancer.

Breast cancer (Tokyo, Japan)·2008
Same author

The role of sentinel lymph node biopsy in Paget's disease of the breast.

Annals of surgical oncology·2007
Same author

Pleomorphic adenoma of the breast: case report and review of the literature.

Diagnostic cytopathology·2005
Same author

A selection algorithm for internal mammary sentinel lymph node biopsy in breast cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2002
Same author

Surgical approach to internal mammary lymph node biopsy.

Journal of the American College of Surgeons·2002

Area of Science:

  • Oncology
  • Surgical Oncology
  • Pathology

Background:

  • Sentinel lymph node (SLN) biopsy is increasingly used for early-stage invasive breast cancer with clinically negative axilla.
  • Mammographic detection identifies more node-negative breast cancer patients, increasing the potential for SLN biopsy to replace axillary dissection.

Purpose of the Study:

  • To evaluate the efficacy and accuracy of sentinel lymph node biopsy in predicting axillary lymph node status for breast cancer patients.
  • To assess the potential of SLN biopsy to reduce morbidity compared to conventional axillary dissection.

Main Methods:

  • Localization of SLNs using radioisotope, blue dye, or a combination of both.
  • Validation of SLN identification through backup axillary dissection during the learning curve.
  • Enhanced pathologic analysis including serial sectioning and immunohistochemical (IHC) staining.

Main Results:

  • Successful SLN localization in over 90% of cases by experienced surgeons.
  • Accurate prediction of axillary node status in 98% of all patients and 95% of node-positive patients.
  • SLN biopsy demonstrated lower morbidity and higher accuracy than conventional axillary dissection in experienced hands.

Conclusions:

  • Sentinel lymph node biopsy is a reliable and accurate method for staging the axilla in early-stage breast cancer.
  • The procedure offers a less morbid alternative to complete axillary dissection for selected patients.
  • Formalized training protocols and enhanced pathologic analysis are crucial for successful SLN biopsy implementation.

Related Experiment Videos